Pharmacokinetics, Safety, and Tolerability Study of the Pen and PFS of SB5 in Healthy Subjects
Clinical trial NCT02326233 · COMPLETED
Trial details
- NCT number
- NCT02326233
- Sponsor
- Samsung Bioepis Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2015-09-01
- Enrollment
- 190
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.